Appendix 1

Author Relationships With Industry and Other Entities—2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation

Committee MemberEmploymentConsultantSpeakerOwnership/Partnership/PrincipalPersonal ResearchInstitutional, Organizational, or Other Financial BenefitExpert Witness
L. Samuel Wann (Chair)Wisconsin Heart and Vascular Clinics—Chairman, Department of Cardiovascular MedicineNoneNoneNoneNoneNoneNone
Anne B. CurtisUniversity of Buffalo—Chair, Department of Medicine
  • Medtronic

  • Sanofi-aventis

  • St. Jude Medical

  • Biotronik

  • Medtronic

  • Sanofi-aventis

None
  • Medtronic

  • St. Jude Medical

None
  • 2009 Plaintiff, pacemaker case

Kenneth A. EllenbogenVirginia Commenwealth University Medical Center—Director, Clinical Electrophysiology Laboratory
  • Atritech

  • Biotronik

  • Boston Scientific

  • GlaxoSmithKline

  • Medtronic

  • Sanofi-aventis

  • St. Jude Medical

  • Biotronik

  • Boston Scientific

  • Medtronic

  • Sanofi-aventis

  • St. Jude Medical

None
  • Atritech

  • Biosense Webster

  • Boston Scientific

  • Medtronic

  • Sanofi-aventis

  • St. Jude Medical

None
N.A. Mark Estes IIINew England Cardiac Arrhythmia Center, Tufts Medical Center—Director; Tufts University School of Medicine, Division of Cardiology—Professor of Medicine
  • Boston Scientific

  • Boston Scientific

  • Medtronic

NoneNoneNone
  • 2008 Defendant, drug toxicity case

Michael D. EzekowitzLankenau Institute for Medical Research—Vice President; Jefferson Medical College–Professor
  • ARYx Therapeutics

  • AstraZeneca

  • Boehringer Ingelheim

  • Bristol-Myers Squibb

  • Daiichi Sankyo

  • Medtronic

  • Portola Pharmaceuticals

  • Sanofi-aventis

  • Wyeth

  • Boehringer Ingelheim

None
  • ARYx Therapeutics

  • Boehringer Ingelheim

  • Daiichi Sankyo

  • Portola Pharmaceuticals

NoneNone
Warren M. JackmanHeart Rhythm Institute, University of Oklahoma Health Sciences Center—G.L. Cross Research Professor Emeritus of Medicine (Cardiology)
  • ACT

  • AtriCure

  • Biosense Webster

  • CardioFocus

  • Endosense

  • Rhythmia Medical

  • Biosense Webster

  • Biotronik

  • Boston Scientific

  • NCME

  • St. Jude Medical

NoneNoneNoneNone
Craig T. JanuaryUniversity of Wisconsin, Madison—Professor of Medicine, Departments of Medicine (Division of Cardiovascular Medicine) and PhysiologyNoneNoneNoneNoneNoneNone
James E. LoweDuke University School of Medicine—Professor of Surgery and PathologyNoneNoneNoneNoneNoneNone
Richard L. PageUniversity of Wisconsin, Madison—Professor of Medicine and Chairman of the Department of MedicineNoneNoneNone
  • Sanofi-aventis

NoneNone
David J. SlotwinerNorth Shore, Long Island Jewish Health Care System—Associate Director, Electrophysiology LaboratoryNoneNoneNoneNoneNoneNone
William G. StevensonBrigham and Women's Hospital, Cardiovascular Division—Director, Clinical Cardiac Electrophysiology ProgramNoneNoneNoneNoneNoneNone
Cynthia M. TracyGeorge Washington University Medical Center—Associate Director, Division of Cardiology; George Washington University Hospital—Director, Cardiac ServicesNoneNoneNoneNoneNoneNone

This table represents the relevant relationships of committee members with industry that were reported orally at the initial writing committee meeting/conference call and updated in conjunction with all meetings and conference calls of the writing committee during the document development process. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $10 000 or more of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships noted in this table are modest unless otherwise noted.

ACCF indicates American College of Cardiology Foundation; AHA, American Heart Association; HRS, Heart Rhythm Society.

  • Significant relationship.

  • Recused from voting on Section 8.1.8.3, Recommendations for Dronedarone.